CD8A and cancer: Using in vitro co-cultures of activated PMEL CD8+ T cells and B16F10 cancer cells, and ex vivo production of PD1+TIM-3+CD8+ T cells, respirometry analysis revealed an increase in oxygen consumption rates (OCR) upon treatment with IL-10-Fc.